GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mizuho Medy Co Ltd (TSE:4595) » Definitions » Price-to-Owner-Earnings

Mizuho Medy Co (TSE:4595) Price-to-Owner-Earnings : 5.97 (As of Sep. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mizuho Medy Co Price-to-Owner-Earnings?

As of today (2024-09-21), Mizuho Medy Co's share price is 円1570.00. Mizuho Medy Co's Owner Earnings per Share (TTM) ended in Dec. 2023 was 円262.98. It's Price-to-Owner-Earnings for today is 5.97.


The historical rank and industry rank for Mizuho Medy Co's Price-to-Owner-Earnings or its related term are showing as below:

TSE:4595' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 3.81   Med: 28.4   Max: 173.21
Current: 5.91

During the past 10 years, the highest Price-to-Owner-Earnings of Mizuho Medy Co was 173.21. The lowest was 3.81. And the median was 28.40.


TSE:4595's Price-to-Owner-Earnings is ranked better than
93.97% of 431 companies
in the Drug Manufacturers industry
Industry Median: 25.44 vs TSE:4595: 5.91

As of today (2024-09-21), Mizuho Medy Co's share price is 円1570.00. Mizuho Medy Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was 円199.63. Therefore, Mizuho Medy Co's PE Ratio for today is 7.86.

As of today (2024-09-21), Mizuho Medy Co's share price is 円1570.00. Mizuho Medy Co's EPS without NRI for the trailing twelve months (TTM) ended in was 円199.63. Therefore, Mizuho Medy Co's PE Ratio without NRI for today is 7.86.

During the past 10 years, Mizuho Medy Co's highest PE Ratio without NRI was 112.25. The lowest was 2.79. And the median was 21.22.


Mizuho Medy Co Price-to-Owner-Earnings Historical Data

The historical data trend for Mizuho Medy Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mizuho Medy Co Price-to-Owner-Earnings Chart

Mizuho Medy Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.73 61.70 6.87 6.23 5.97

Mizuho Medy Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 5.97 - -

Competitive Comparison of Mizuho Medy Co's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Mizuho Medy Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mizuho Medy Co's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mizuho Medy Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Mizuho Medy Co's Price-to-Owner-Earnings falls into.



Mizuho Medy Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Mizuho Medy Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1570.00/262.98
=5.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mizuho Medy Co  (TSE:4595) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Mizuho Medy Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Mizuho Medy Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Mizuho Medy Co Business Description

Traded in Other Exchanges
N/A
Address
4 Fujinoki-Machi, Saga Prefecture, Tosu, JPN, 841-0048
Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.

Mizuho Medy Co Headlines

No Headlines